A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A

Active, not recruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

June 30, 2023

Primary Completion Date

June 6, 2028

Study Completion Date

September 17, 2030

Conditions
Hemophilia A
Interventions
DRUG

Efanesoctocog Alfa BIVV001

Given per investigator's discretion

Trial Locations (28)

61615

The Bleeding and Clotting Disorders Institute- Site Number : 8400005, Peoria

77030

Gulf States Hemophilia and Thrombophilia Center- Site Number : 8400029, Houston

89109

Children's Specialty Center - Las Vegas- Site Number : 8400007, Las Vegas

90007

Orthopedic Institute for Children- Site Number : 8400004, Los Angeles

92868

The Center for Inherited Blood Disorders- Site Number : 8400001, Orange

85234-2165

Banner MD Anderson Cancer Center- Site Number : 8400008, Gilbert

92354-3450

Loma Linda University- Site Number : 8400015, Loma Linda

80045-7202

University of Colorado Hemophilia and Thrombosis Center- Site Number : 8400019, Aurora

32610-3003

William A. Shands Hospital at the University of Florida- Site Number : 8400032, Gainesville

33701-4804

Johns Hopkins All Childrens Hospital - Outpatient Care Center - PIN- Site Number : 8400025, St. Petersburg

60612-3863

Rush University Medical Center -1725 W Harrison St- Site Number : 8400014, Chicago

46260-1920

Indiana Hemophilia and Thrombosis Center- Site Number : 8400013, Indianapolis

52242-1009

University Of Iowa Hospitals And Clinics- Site Number : 8400026, Iowa City

02114

~Massachusetts General Hospital- Site Number : 8400017, Boston

02215-5418

Dana Farber and Boston Children's Hospital- Site Number : 8400031, Boston

48109-5000

University of Michigan Hospital - 1500 E Medical Center Dr- Site Number : 8400023, Ann Arbor

55455-4800

M Health Fairview- Masonic Cancer Clinic - Clinics- Site Number : 8400010, Minneapolis

55905-0001

Mayo Clinic - PPDS- Site Number : 8400035, Rochester

39110-6115

Mississippi Center For Advanced Medicine - 7731 Old Canton Rd- Site Number : 8400016, Madison

68114-4113

University of Nebraska Medical Center - 985400 Nebraska Medical Center- Site Number : 8400009, Omaha

10065-4870

Weill Cornell Medicine-New York Presbyterian Hospital- Site Number : 8400021, New York

45229-3026

Cincinnati Children's Hospital Medical Center - PIN- Site Number : 8400006, Cincinnati

15213-4306

Hemophilia Center of Western Pennsylvania- Site Number : 8400012, Pittsburgh

37232-0011

Vanderbilt University Medical Center- Site Number : 8400003, Nashville

75390-7202

University of Texas Southwestern Medical Center-2001 Inwood Rd- Site Number : 8400020, Dallas

75390-8565

University of Texas Southwestern Medical Center- Site Number : 8400011, Dallas

98101-3932

Washington Institute for Coagulation- Site Number : 8400022, Seattle

53233-2121

Blood Center of Wisconnsin- Site Number : 8400027, Milwaukee

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT05911763 - A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A | Biotech Hunter | Biotech Hunter